Attend a Workshop

View Online Corporate Workshops (OCWs) are free for all attendees. They are a year-round extension of the popular Corporate Workshops presented each year at the AMP Annual Meeting. They are free to the public and therefore are valuable opportunities for everyone to learn to learn from industry representatives and scientific experts about the latest advances and instrumentation relevant to molecular diagnostics and research. OCWs are presented on weekday afternoons for one hour, and are conducted by commercial companies. Upcoming OCWs will be announced to AMP members on CHAMP, including registration information, as well as posted on this webpage.

Terms of Use and Disclaimers

Register for an Upcoming OCW




View an Archived OCW

Access is available for a limited time. There is no fee or membership requirement to access archived OCWs.


Invivoscribe - March 20, 2024

Level Up Your MRD Testing: Leveraging Standardized & Sensitive AML Assessments

Speakers: Tony Sanchez, M.D.
Technical Account Manager

Josh Wemmer, M.S.
Sr. Bioinformatician

View Now


Illumina - December 5, 2023 

Comprehensive Genomic Testing and Targeted Therapies in NSCLC and Thyroid Cancer Patients with Gene Fusions

Lori Wirth, MD
Medical Director, Center for Head and Neck Cancers
Massachusetts General Hospital

Carlo Bifulco, MD
Chief Medical Officer
Providence Genomics

This Corporate Workshop is also supported by Bayer.

View Now


Integrated DNA Technologies - November 7, 2023 


Comprehensive, Reliable Answers for Heme Malignancies with Customized Archer™ NGS assays

Barbara Anderson, PhD, MB (ASCP)CM
Analytical Specialist
Division of Molecular Pathology, Genetics and Genomics
Duke University Health System

Ludmila Francescatto, PhD
Laboratory Genetics & Genomics Fellow
Division of Molecular Pathology, Genetics and Genomics
Duke University Health System

View Now


Invivoscribe - May 31, 2023 

NGS Assessment of SHM in CLL/SLL: A Practical Comparison of Platforms & Primers

Kseniya Petrova-Drus, MD, PhD
Assistant Attending Pathologist
Hematopathology and Diagnostic Molecular Pathology
Memorial Sloan Kettering

View Now


Asuragen - January 12, 2023 

Diverse Data Matters: Implementing a Simple Yet Comprehensive PCR/CE Based CFTR Kit

Andrea Ferreira-Gonzalez, PhD HCLD(ABB), CC(ABB), FACC
Professor and Chair, Division Molecular Diagnostics
Director, Molecular Diagnostics Laboratory
Virginia Commonwealth University

Ninad Pendsé, MS, MBA
Senior Product Manager
Asuragen, a Bio-Techne Brand

View Now


Invivoscribe - November 15, 2022

Lab Secrets: NGS-based MRD Testing for Acute Lymphoblastic Leukemia - the Austin Experience

Rishu Agarwal, MBBS PhD FRCPA
Molecular Haematologist
Austin Health & Peter MacCallum Cancer Center
Melbourne, Australia

Stephen B. Ma, BbiomedSc BSc(Hon) MD DipMus LMusA(dist)
Laboratory Haematology Registrar
Austin Health
Melbourne, Australia

View Now


QIAGEN - Wednesday August 31st, 2022

Xerna TME™ Panel: An RNA-Based Investigational Assay Designed to Predict Patient Response to Anti-Angiogenic and Immune Targeted Therapies

Mark Uhlik
Vice President, Head of Research & Biomarker Discovery
OncXerna Therapeutics

View Now


QIAGEN - Tuesday August 23rd, 2022 

Faster, simpler, more efficient: The latest improvements in NGS workflows for targeted DNA sequencing

Krishna Amin
Senior Global Product Manager, Targeted NGS

Sophie Fiola
Field Application Scientist, Clinical Customers
QIAGEN Diagnostics

View Now

Janssen - Thursday July 14th, 2022

Precision Medicine: Exon 20 Marks the Spot - EGFR Exon 20 Mutations in Non-Small Cell Lung Cancer (NSCLC)

Hatim Husain, MD
Associate Professor of Medicine
University of California, Moores Cancer Center

Eric Vail, MD
Director, Molecular Pathology
Assistant Professor, Pathology & Laboratory Medicine
Cedars-Sinai Medical Center


Genentech - Wednesday June 15, 2022

Medicare Coverage of Next Generation Sequencing: Pulling Back the Curtain on the What, Why, & How of Medicare Coverage Testing

Gabriel Bien-Willner, MD, PhD, FCAP
Medical Director of MolDX
Chief Medical Officer, Palmetto GBA

View Now


Invivoscribe - Thursday February 24, 2022

Stratification and Prognoses of Leukemia and Multiple Myeloma using Next-Generation Sequencing (NGS)

Riccardo Bomben, MD
Clinical & Experimental Onco-Hematology Unit
IRCCS CRO Aviano, Italy

Wouter De Brouwer, MD
Vrije Universiteit Brussel (VUB)
Universitaire Ziekenhuis Brussel
Department of Hematology
Brussels, Belgium

View Now


Invivoscribe MRD Software
Invivoscribe Study of MRD
Lympho Track - MiSeq Workflow
Lympho Track S5PGM Workflow


Takeda - Thursday January 27, 2022 

EGFR Exon 20 Insertions: Distinct EGFR Mutations in NSCLC with Practical Application

Dr. Michelle Shiller, DO, MSPT
Co-Medical Director, Cancer Genetics
Baylor University Medical Center

Dr. Tarek Mekhail, MD
Medical Director, Thoracic Cancer Program
AdventHealth Cancer Institute

View Now


Asuragen - Thursday December 9, 2021

Practical and Reliable CFTR Variant Detection for Diverse Populations with the AmplideX® PCR/CE CFTR Kit


John Milligan, PhD
Senior Manager, R&D, Asuragen

View Now


Invivoscribe - Thursday October 28, 2021

Explore the Benefits, Considerations, and Utility of NGS B- and T-cell Clonality Testing 


B. Melody Zhang, MD, MS, FCAP, A(ACHI) 
Stanford University, School of Medicine

Bijal A Parikh, MD, PhD 
Washington University School of Medicine

View Now


IDT - Wednesday September 22, 2021

IDT GMP and OEM Capabilities


Mitch Gore
Commercial & Technical Manager for the B2B, qPCR, and Custom Oligo Product Lines

Renee Rathjen
GMP Product Manager

View Now


QIAGEN -  August 25, 2021 - 11:00am Eastern

Ultra-sensitive NGS-based Liquid Biopsy Technology in Companion Diagnostics


Frederick S. Jones, PhD
Senior Director, Life Science Medical Affairs
Sysmex Inostics

Johannes Fredebohm, PhD
Head of Research and Innovation
Sysmex Inostics

Dr. Reinhard Ortmann
Director Companion Diagnostics

View Now

View Slide Deck


QIAGEN - May 27, 2021 - 1:00pm Eastern

The COVID-19 Challenge: The Diagnostic Laboratory Experience


Heba Mostafa, MD, PhD
Johns Hopkins

Jason Ong
Senior Director Marketing, NeuMoDx

View Now


Amgen - April 28, 2021 - 12:00pm Eastern

KRAS G12C - A Key Emerging Biomarker in the Pathogenic Evaluation of NSCLC


Pranil K. Chandra, DO, FCAP, FASCP
Chief Medical Officer of Genomic and Clinical Pathology

View Now


Illumina - March 31, 2021 - 2:00pm Eastern

Testing Methodologies for Optimal Identification of Rare Fusion Events


Susan Hsiao, MD, PhD
Assistant Professor of Pathology & Cell Biology
Columbia University

View Now


AstraZeneca - February 24, 2021 - 1:00pm Eastern

A Multidisciplinary Approach for Patients with Resectable NSCLC


Shirley Michelle Shiller, DO, MSPT
Co-Director, Medical Genetics; Staff Pathologist
Baylor Sammons Cancer Center, Baylor University Medical Center 
Dallas, TX

View Now


Bristol Myers Squibb - December 16, 2020 - 12:00pm Eastern

Translatability of Tumor Inflammation Gene Signatures & Blood-Based Biomarkers of Immuno-Oncology


Nancy Zhang, MD
Associate Director, Pharmacodiagnostics and Precision Medicine, BMS 

Jonathan Baden
Senior Director Pharmacodiagnostic, BMS

View Now


Canaxia Health - November 4, 2020 - 1:00pm Eastern

Treating Late Stage Cancer Patients During a Pandemic: An International and Multidisciplinary Perspective


David Huntsman, MD, FRCPC, FCCMG
Chew Wei Memorial Professor of Gynaecologc Oncology,
Professor: Departments of Pathology and Laboratory Medicine and Obstetrics and Gynaecology: UBC (CANADA)

William G. Morice, II, M.D., Ph.D. 
Chair of the Department of Laboratory Medicine and Pathology
President of Mayo Labs Rochester, MN, (U.S.A)

Joerg Kriegsmann 
Medical Director of Sonic Germany, aka Molecular Pathologie Trier, (GERMANY)

Rosalyn Juergens, B.S. (Hons), MD., PhD
Associate Professor, Department of Oncology, McMaster University 
Adjunct Assistant Professor, Department of Oncology, The Johns Hopkins Medical Institute (CANADA).

View Now


AstraZeneca - July 29, 2020 - 1:00pm Eastern

Liquid Biopsy Testing Strategies for Patients with Metastatic NSCLC
John W. Longshore, PhD, FACMG
Director, Molecular Pathology Laboratory
Atrium Health, formerly Carolinas HealthCare System
Carolinas Pathology Group
Charlotte, North Carolina

View Now


QIAGEN - June 26, 2020 - 11:00am

Tackling COVID-19 through Syndromic Testing – QIAstat-Dx Respiratory SARS-CoV-2 Panel
Davide Manissero, MD, MRCPCH, MSc, DTM&H
VP, Head of Medical Affairs & Chief Medical Officer
Infection & Immune Diagnostics, QIAGEN
View Now


AstraZeneca - May 28, 2020 - 1:00 PM Eastern

Molecular Testing for Alterations in DNA Damage Repair Pathway Genes in Ovarian & Prostate Cancer: Why, Who, & How to Test
Samuel Caughron, MD, FCAP
Pathologist, President & CEO, MAWD Pathology Group
Chair of Pathology & Medical Director of Clinical Laboratory, Advent Health Kansas City
View Now


QIAGEN - May 12, 2020 - 10:00 AM Eastern

Learn how to implement a streamlined, single NGS workflow for the analysis of DNA and RNA – all from a single sample
Sylvia Herold, PhD 
Institut für Pathologie 
Universitätsklinikum Dresden
View Now


Bristol Myers Squibb - April 9, 2020 - 1:00 PM Eastern

Current and Emerging Biomarkers: Science, Technology, & Practicalities
Tabetha Sundin, PhD, HCLD (ABB), MB(ASCP)
Scientific Director 
Molecular Diagnostics & Serology
Sentara Healthcare
View Now


INVIVOSCRIBE - February 27, 2020 - 1:00 PM Eastern

Utility of NGS Assays for the Evaluation of Lymphoid Malignancies
Yury Monczak, PhD, Scientific Co-Director, Molecular Pathology Center, McGill University Health Center, Jewish General Hospital, Assistant Professor, McGill University
Bevan Tandon MD, Director, Cancer Genomics, BioReference Laboratories, an OPKO Health Company
View Now


HOLOGIC - January 30, 2020 - 2:00 PM Eastern

New Tools to Overcome Challenges in Vaginitis Diagnosis and Treatment
Presenter:  Jane Schwebke, MD, Professor of Medicine – Infectious Disease Division, University of Alabama - Birmingham
View Now


QIAGEN - December 18, 2019 - 11:00 AM Eastern 

The Power of ONE: Introducing a Novel 1-Day Workflow for Simultaneous High-Sensitivity Analysis of DNA Variants & RNA Fusions
Presenter:Jonathan Shaffer, PhD, MBA, Associate Director, NGS Assay Research & Development, QIAGEN
View Now


QIAGEN - December 12, 2019 - 11:00 AM Eastern

Experience the Power of ONE: Simultaneous Detection of DNA Variants & RNA Fusions in 1-Day Workflow from Sample to Sequencing
George J. Quellhorst, Jr., PhD Associate Director, R&D, QIAGEN;
Andrew Cassidy, PhD, Marketing Project Manager, Enterprise Genomic Services, QIAGEN
View Now


QIAGEN - August 20, 2019 - 1:00 PM Eastern

Implementation of a Cost-Effective NGS Program in a Laboratory with Limited Resources.
Yassmine Akkari, PhD, Legacy Health
Eva Szarek, PhD, QIAGEN
View Now


Invivoscribe - July 23, 2019 - 1:00 PM Eastern

Minimal Residual Disease Detection of B-lymphoid and Plasma Cell Neoplasm Using a NGS-Based Clonal IGH Rearrangement Assay
Caleb Ho, MD Memorial Sloan Kettering Cancer Center
Ryan Schmidt, MD, PhD, University of Southern California/Children’s Hospital, Los Angeles
View Now


QIAGEN - June 20, 2019 - 1:00 PM Eastern

A Pathologist's Guide to Companion Diagnostics and Precision Medicine in Oncology
Presenters: Anjen Chenn, MD, PhD, Sr Director Molecular Diagnostics, LabCorp
Jennifer Quigley, Director Oncology Product Commercialization, LabCorp – Integrated Oncology
Benjamin Chaffey, PhD, Global Product Manager, QIAGEN
View Now


Hologic - May 30, 2019, 2:00 PM Eastern

Syndromic Respiratory Testing in a Dynamic Reimbursement Landscape
James Dunn, PhD,Director, Medical Microbiology & Virology Lab, Texas Children’s & Baylor Hospitals
Paul Radensky, MD, JD, Principal, McDermott Consulting
View Now


Bristol-Myers Squibb - February 28, 2019

Pathology Leadership in Biomarker Testing: Pre-Analytical Phase
Presenter: Michelle Shiller, DO, Baylor University Medical Center
View Now

Beckman Coulter Life Sciences - October 4, 2018

Mutational Signatures in Cytogenetics Risk Groups of Newly Diagnosed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Presenter: Robyn Sussman, PhD, Hospital of the University of Pennsylvania
Moderator: Jung Doh, PhD, Beckman Coulter Life Sciences
View Now
Handout (PDF)


AMP EUROPE 2018: Achieving Dramatic Insights into Molecular Oncology and Precision Medicine
April 30- May 2, 2018


Agena Bioscience

Why Liquid Biopsy is Important in Clinical Routine...
Presenter: Ron van Schaik
Rotterdam, The Netherlands
View Now

ALK-EML4 Fusions in ctDNA of Lung Cancer Patients in Clinical Practice
Presenter: Antoinette Lemoine
Paris, France
View Now

INVIVOSCRIBE - April 17, 2018

Complete Suite of NGS Clonality Assays with Bioinformatics - Identification and Tracking Patient-specific Clones
Presenters: Presha Shah, PhD and Kasey Hutt, PhD
Invivoscribe, San Diego, CA
View Now
LymphoTrack Portfolio - MiSeq
LymphoTrack Portfolio - Ion PGM

HOLOGIC - February 22, 2018

Mycoplasma genitalium Infection: An Emerging Sexually Transmitted Infection
Presenter: William M. Geisler MD, MPH
University of Alabama at Birmingham
View Now

INVIVOSCRIBE - October 10, 2017

NGS Clonality Testing: Assessing Clonality Status, Somatic Hypermutation and Monitoring Minimum Residual Disease (MRD)
Presenter: Maria Arcila, MD
Moderator: Jeff Miller, PhD
View Now

Philips Healthcare IT-Genomics - March 14, 2017

Challenges in Genomic Aberration Detection and Interpretation in Solid Tumors and Evidence-based Approaches for Targeted Therapy
Presenters: Nevenka Dimitrova, PhD and Sheryl Elkin, PhD
Moderator: Autri Dutta, PhD
View Now

Philips Healthcare IT- October 31, 2016

Genetics in Clinical Diagnostics
Presenter: Michael Snyder, PhD
Moderator: Nevenka Dimitrova, PhD
View Now (Audio starts at 1:15)


Monitoring Deep Molecular Response: A Sensitive and Robust FDA Cleared Assay for CML
Presenters: Bernard F. Andruss, PhD and Y. Lynn Wang, MD, PhD, FCAP
Moderator: Ninad Pendsé, MBA
View Now

Personalis - October 29, 2015

Comprehensive Tumor Characterization Using Augmented NGS
Presenter: Christelle Johnson, PhD
Moderator: Erin Newburn, PhD
View Now

Personalis - October 16, 2015

Achieving High Diagnostic Yield for Clinically Relevant Genes: How to ‘ACE' Exome Sequencing
Presenter: Heather Wetzel, MS, LCGC
Moderator: Felicia Hawthorne, PhD
View Now

Corporate Partners